Form 4: Zivo Bioscience Director Nola E. Masterson Reports Acquisition of Common Stock

Director Nola E. Masterson reports acquiring additional shares of Zivo Bioscience common stock on January 1, 2025.

Summary

• Nola E. Masterson, a director of Zivo Bioscience, Inc., filed a Form 4 on January 3, 2025, reporting changes in beneficial ownership.
• On January 1, 2025, Masterson acquired 1,354 shares of common stock at $0, increasing her direct holdings to 123,378 shares.
• Additionally, on the same date, Masterson acquired another 7,528 shares of common stock at $0, further increasing her direct holdings to 130,906 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of stock acquisitions by a director. The fact that a director is increasing their holdings could be seen as slightly positive, but without more context, it's difficult to gauge the overall impact.

Positives

• A director's increased investment in the company may signal confidence in its future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers regarding their company's stock.

Stakeholder Impact

• The increased holdings by a director could be viewed positively by shareholders.

Key Dates

Keywords

Zivo Bioscience, Director, Form 4, Beneficial Ownership, Stock Acquisition, Masterson, ZIVO